Surgical Aortic Valve Repair (AVR) is the gold standard and an effective treatment of severe aortic stenosis and has been proven to provide symptomatic relief and long-term survival in adults. During the surgical valve replacement procedure, the damaged heart valve is removed and replaced with a prosthetic valve. Surgical AVR is recommended for virtually all adult patients who do not have other serious medical conditions.
For patients who have been deemed inoperable for traditional open-heart surgery by a surgeon, a new procedure available at INTEGRIS Heart Hospital, called transcatheter aortic valve replacement (TAVR) is now an option for non-surgical treatment. In November of 2011, the Food and Drug Administration (FDA) approved the Edwards SAPIEN Transcatheter Heart Valve for the treatment of patients with severe symptomatic native aortic valve stenosis who have been determined by a cardiac surgeon to be inoperable for open valve replacement.
Other possible treatment options include:
- Following a heart-healthy lifestyle for prevention against valve disease.
- Your physician may adopt a “watch and wait” policy for mild or asymptomatic cases.
- Medications may be prescribed such as antithrombotic medications or anticoagulants (especially following valve replacement surgery).
- Balloon dilatation (a surgical technique involving insertion into a blood vessel of a small balloon that is led via catheter to the narrowed site and then inflated) may be done to widen a stenotic valve.